CD8A and neoplasm: We observed that the EV-Ligand treatment induced significantly higher levels of tumor cell death as compared with an equivalent quantity of free ligand at all ratios tested with both splenocyte and CD8+ T cell co-cultures (Figures S7E and S7F).